Figure 3.

Melanoma gene-expression markers of survival

(A) Kaplan-Meier curve by expression subtype for TCGA melanoma stage III/IV patients

(B) Heatmap of marker gene expression for pre-immunotherapy (primary cohort n = 154) patients grouped by subtype

(C and D) Kaplan-Meier curve by subtype for primary cohort (C) and for immune subtype patients (D)

(E) Differential expression between patients with OS >1 year (long OS) and patients with OS <1 year (short OS) in the primary cohort using DESeq2.

(F) Expression of differentially expressed genes in melanoma CCLE cell lines and Human Protein Atlas blood cell types